Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.9200
+0.0160 (1.77%)
Jul 31, 2026, 11:05 AM CET
Biosynex Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.46 | 4.69 | 20.17 | 87.17 | 132.03 |
Short-Term Investments | - | 5 | 6 | - | - |
Cash & Short-Term Investments | 8.46 | 9.69 | 26.16 | 87.17 | 132.03 |
Cash Growth | -12.75% | -62.96% | -69.99% | -33.98% | 258.43% |
Accounts Receivable | 7.82 | 7.1 | 10.65 | 14.7 | 25.27 |
Other Receivables | 16.42 | 14.94 | 10.67 | 18.86 | 9.41 |
Total Trade Receivables | 24.24 | 22.04 | 21.31 | 33.56 | 34.67 |
Inventory | 22.87 | 32.67 | 38.21 | 37.67 | 31.15 |
Other Current Assets | - | - | 5.66 | 1.2 | 0.92 |
Total Current Assets | 55.56 | 64.39 | 91.35 | 159.61 | 198.78 |
Net Property, Plant & Equipment | 8.5 | 14.85 | 16.1 | 8.74 | 5.26 |
Other Intangible Assets | 69.24 | 113.01 | 131.34 | 86.86 | 52.13 |
Long-Term Investments | 2.94 | 2.44 | 2.93 | 5.14 | 12.77 |
Total Assets | 136.24 | 194.69 | 241.73 | 260.34 | 268.94 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 17.15 | 16.31 | 15.07 | 14.99 | 18.73 |
Accrued Expenses | - | - | 9.69 | 9.38 | 28.03 |
Other Current Liabilities | 12.9 | 26.88 | - | - | - |
Total Current Liabilities | 30.05 | 43.19 | 24.76 | 24.37 | 46.76 |
Long-Term Debt | 61.65 | 62.63 | 65.96 | 52.08 | 35.31 |
Other Long-Term Liabilities | 7.66 | 4.56 | 22.84 | 14.92 | 17.32 |
Total Long-Term Liabilities | 69.31 | 67.18 | 88.81 | 67 | 52.63 |
Total Liabilities | 99.35 | 110.38 | 113.56 | 91.36 | 99.39 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.88 | 1.08 | 1.08 | 1.03 | 1.11 |
Additional Paid-in Capital | 32.78 | 25.6 | 25.6 | 25.6 | 47.27 |
Retained Earnings | 0.29 | 53.9 | 97.81 | 135.91 | 119.42 |
Total Common Shareholders' Equity | 34.95 | 80.58 | 124.48 | 162.53 | 167.81 |
Minority Interest | 1.94 | 3.74 | 7.54 | 8.53 | 3.51 |
Shareholders' Equity | 36.89 | 84.31 | 128.17 | 168.98 | 169.56 |
Total Liabilities & Equity | 136.24 | 194.69 | 241.73 | 260.34 | 268.94 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 61.65 | 62.63 | 65.96 | 52.08 | 35.31 |
Net Cash (Debt) | -53.19 | -52.94 | -39.8 | 35.1 | 96.72 |
Net Cash Growth | - | - | - | -63.71% | 359.13% |
Net Cash Per Share | -2.84 | -4.92 | -3.98 | 1.73 | 17.62 |
Book Value | 34.95 | 80.58 | 124.48 | 162.53 | 167.81 |
Book Value Per Share | 1.87 | 7.49 | 12.45 | 8.01 | 30.57 |
Tangible Book Value | -34.29 | -32.43 | -6.86 | 75.67 | 115.67 |
Tangible Book Value Per Share | -1.83 | -3.02 | -0.69 | 3.73 | 21.07 |